Vascular targeting in pancreatic cancer: the novel tubulin-binding agent ZD6126 reveals antitumor activity in primary and metastatic tumor models.

Vascular targeting in pancreatic cancer: the novel tubulin-binding agent ZD6126 reveals antitumor activity in primary and metastatic tumor models.

Item
http://www.wikidata.org/entity/Q41552582
A review of the past, present, and future directions of neoplasiaNeoplasia: Where We Have Been and Where We Are GoingIntravital microscopy of tumor angiogenesis and regression in the dorsal skin fold chamber: mechanistic insights and preclinical testing of therapeutic strategies.Non-invasive in vivo imaging of vessel calibre in orthotopic prostate tumour xenografts.Multiparametric MRI biomarkers for measuring vascular disrupting effect on cancerKML001 displays vascular disrupting properties and irinotecan combined antitumor activities in a murine tumor model.The Blood Flow Shutdown Induced by Combretastatin A4 Impairs Gemcitabine Delivery in a Mouse HepatocarcinomaIncreased expression of αTubulin is associated with poor prognosis in patients with pancreatic cancer after surgical resection.Neoplasia: An Anniversary of Progress.
P2860

Vascular targeting in pancreatic cancer: the novel tubulin-binding agent ZD6126 reveals antitumor activity in primary and metastatic tumor models.

Item
http://www.wikidata.org/entity/Q41552582
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Vascular targeting in pancreat ...... y and metastatic tumor models.
@en
type
label
Vascular targeting in pancreat ...... y and metastatic tumor models.
@en
prefLabel
Vascular targeting in pancreat ...... y and metastatic tumor models.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P932
P356
P1433
P1476
Vascular targeting in pancreat ...... ry and metastatic tumor models
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P932